ENTRY       D00707                      Drug
NAME        Fomepizole (JAN/USAN/INN);
            Antizol (TN)
PRODUCT
  GENERIC   FOMEPIZOLE (American Regent)
            FOMEPIZOLE (American Regent)
            FOMEPIZOLE (Gland Pharma Limited)
            FOMEPIZOLE (Mylan Institutional LLC)
            FOMEPIZOLE (Navinta LLC)
            FOMEPIZOLE (Zydus Pharmaceuticals USA)
FORMULA     C4H6N2
EXACT_MASS  82.0531
MOL_WEIGHT  82.1038
CLASS       Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
             DG01525  CYP2A6 inhibitor
             DG01643  CYP2C9 inhibitor
             DG01645  CYP2D6 inhibitor
             DG02884  CYP2E1 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
REMARK      Same as: C07837
            Therapeutic category: 3929
            ATC code: V03AB34
            Product: D00707<JP/US>
EFFICACY    Antidote (ethyleneglycol, methanol), Alcohol dehydrogenase inhibitor
TARGET      ADH [HSA:124 125 126] [KO:K13951]
  PATHWAY   hsa00980(124+125+126)  Metabolism of xenobiotics by cytochrome P450
INTERACTION CYP inhibition: CYP2D6 [HSA:1565], CYP2E1 [HSA:1571], CYP1A2 [HSA:1544], CYP2A6 [HSA:1548], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB34 Fomepizole
                  D00707  Fomepizole (JAN/USAN/INN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               392  Antidotes
                3929  Others
                 D00707  Fomepizole (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               D00707  Fomepizole
              DG01525  CYP2A6 inhibitor
               D00707  Fomepizole
              DG01643  CYP2C9 inhibitor
               D00707  Fomepizole
              DG01645  CYP2D6 inhibitor
               D00707  Fomepizole
              DG02884  CYP2E1 inhibitor
               D00707  Fomepizole
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                D00707  Fomepizole
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Dehydrogenases
                ADH
                 D00707  Fomepizole (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00707
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00707
DBLINKS     CAS: 7554-65-6
            PubChem: 7847772
            ChEBI: 5141
            PDB-CCD: 4PZ
            LigandBox: D00707
            NIKKAJI: J35.396E
ATOM        6
            1   C8y C    21.8459  -16.2459
            2   C8x C    23.2400  -16.2459
            3   C8x C    21.4084  -14.9216
            4   C1a C    20.8425  -17.2317
            5   N5x N    23.6775  -14.9216
            6   N4x N    22.5459  -14.0931
BOND        6
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     5   6 1
///
